This content is from: Premium Corvex Settles With SEC Over SPAC Activities Shares of the hedge fund’s three SPAC merger partners have plummeted. By Stephen Taub April 17, 2023
This content is from: Premium Sylebra Capital Makes Two Activist Moves The firm is targeting RingCentral and 8x8. By Stephen Taub May 30, 2023
This content is from: Corner Office Why So Many Superannuation Funds Are Merging Fees and government reforms are driving consolidation among Australian retirement funds. By Alicia McElhaney April 05, 2023
This content is from: Portfolio Australian Allocators Wrestle With ‘Clumsy’ Regulation APRA’s recent regulatory changes have received mixed reviews from superannuation funds. By Alicia McElhaney May 04, 2023
This content is from: Premium SPAC Bankruptcies Rock Hedge Funds Deals made before the market selloff are falling apart. By Stephen Taub March 13, 2023
This content is from: Premium Biopharma Deals Offer Hope for Future Public Listings Investors are cautiously optimistic that the sector’s long drought could be coming to an end. By Stephen Taub March 27, 2023
